abstract |
The present invention relates to a co-micronized product, which includes an active ingredient selected from the group consisting of ulipristal acetate, ulipristal acetate metabolites and mixtures thereof, and a pharmaceutically acceptable solid surfactant. The invention also relates to a pharmaceutical composition comprising said co-micronized product and its therapeutic use. |